Radiopharm Theranostics Limited
RADX
$7.03
-$0.42-5.64%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 2.11% | 56.54% | |||
| Total Other Revenue | 2.12% | 614.94% | |||
| Total Revenue | 2.12% | 297.93% | |||
| Cost of Revenue | 2.12% | 0.66% | |||
| Gross Profit | -2.12% | 56.08% | |||
| SG&A Expenses | 2.12% | 29.98% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 2.12% | 9.93% | |||
| Operating Income | -2.12% | 25.51% | |||
| Income Before Tax | -2.12% | 7.90% | |||
| Income Tax Expenses | 0.00% | -97.87% | |||
| Earnings from Continuing Operations | -2.12% | 8.36% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -2.12% | -196.25% | |||
| Net Income | -2.12% | -0.85% | |||
| EBIT | -2.12% | 25.51% | |||
| EBITDA | -2.12% | 25.01% | |||
| EPS Basic | -3.85% | 21.21% | |||
| Normalized Basic EPS | 0.00% | 30.00% | |||
| EPS Diluted | -3.85% | 21.21% | |||
| Normalized Diluted EPS | 0.00% | 30.00% | |||
| Average Basic Shares Outstanding | 0.00% | 26.72% | |||
| Average Diluted Shares Outstanding | 0.00% | 26.72% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||